✨
AI Summary
- Emerging class of oncology drugs: bispecific antibodies.
- Discussion with oncology analysts Neha Anand and David Dahan.
- Insights into their mechanism and potential.
Guests on This Episode
DD
David Dahan
3 podcast appearances
NA
Neha Anand
3 podcast appearances